Medclair AB (NGM:MCLR)

Medclair AB Statistics

Total Valuation

Medclair AB has a market cap or net worth of SEK 234.28 million. The enterprise value is 232.49 million.

Market Cap	234.28M
Enterprise Value	232.49M

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Medclair AB has 82.49 million shares outstanding. The number of shares has decreased by -4.21% in one year.

Current Share Class	82.49M
Shares Outstanding	82.49M
Shares Change (YoY)	-4.21%
Shares Change (QoQ)	+51.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 44.87.

PE Ratio	44.87
Forward PE	n/a
PS Ratio	4.71
PB Ratio	4.19
P/TBV Ratio	10.48
P/FCF Ratio	65.46
P/OCF Ratio	41.72
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.03, with an EV/FCF ratio of 64.96.

EV / Earnings	44.53
EV / Sales	4.67
EV / EBITDA	24.03
EV / EBIT	41.93
EV / FCF	64.96

Financial Position

The company has a current ratio of 3.02

Current Ratio	3.02
Quick Ratio	1.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	24.64

Financial Efficiency

Return on equity (ROE) is 9.80% and return on invested capital (ROIC) is 6.51%.

Return on Equity (ROE)	9.80%
Return on Assets (ROA)	5.58%
Return on Invested Capital (ROIC)	6.51%
Return on Capital Employed (ROCE)	9.92%
Revenue Per Employee	3.55M
Profits Per Employee	372,929
Employee Count	14
Asset Turnover	0.80
Inventory Turnover	1.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +93.20% in the last 52 weeks. The beta is 1.03, so Medclair AB's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	+93.20%
50-Day Moving Average	3.09
200-Day Moving Average	2.16
Relative Strength Index (RSI)	41.75
Average Volume (20 Days)	123,392

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medclair AB had revenue of SEK 49.74 million and earned 5.22 million in profits.

Revenue	49.74M
Gross Profit	35.49M
Operating Income	5.55M
Pretax Income	5.22M
Net Income	5.22M
EBITDA	9.67M
EBIT	5.55M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 1.79 million in cash and n/a in debt, giving a net cash position of 1.79 million or 0.02 per share.

Cash & Cash Equivalents	1.79M
Total Debt	n/a
Net Cash	1.79M
Net Cash Per Share	0.02
Equity (Book Value)	55.88M
Book Value Per Share	n/a
Working Capital	16.76M

Cash Flow

In the last 12 months, operating cash flow was 5.62 million and capital expenditures -2.04 million, giving a free cash flow of 3.58 million.

Operating Cash Flow	5.62M
Capital Expenditures	-2.04M
Free Cash Flow	3.58M
FCF Per Share	0.04

Margins

Gross margin is 71.35%, with operating and profit margins of 11.15% and 10.50%.

Gross Margin	71.35%
Operating Margin	11.15%
Pretax Margin	10.50%
Profit Margin	10.50%
EBITDA Margin	19.45%
EBIT Margin	11.15%
FCF Margin	7.20%

Dividends & Yields

Medclair AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.21%
Shareholder Yield	4.21%
Earnings Yield	2.23%
FCF Yield	1.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7